Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

APOBANK REGIONAL DEVELOPMENT GL I

Signature(s)

Amount
€ 100,000,000
Countries
Sector(s)
Germany : € 100,000,000
Credit lines : € 100,000,000
Signature date(s)
9/08/2004 : € 100,000,000
Link to source
Data sheet
APOBANK REGIONAL DEVELOPMENT GL I
Other links
Summary sheet
Apobank Regional Development Global Loan I

Summary sheet

Release date
17 February 2004
Status
Reference
Signed | 09/08/2004
20030218
Project name
Promoter - financial intermediary
Apobank Regional Development Global Loan I
Deutsche Apotheker- und Aerztebank eG, Düsseldorf.
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
Up to EUR 100 m.
Approximately EUR 200m.
Location
Sector(s)
Description
Objectives

Projects of limited scale in the field of medical professions. The projects will include investments in medical practices (premises and medical equipment) of doctors, dentists and veterinarians as well as pharmacies, exclusively located in assisted areas (objective 1 or 2) within the EU, mainly in Germany.

With an exclusive focus on the medical professions and a market share of more than 50%, Apobank plays a central role as financial intermediary in this segment, which, by its very nature, is traditionally dominated by small-scale private enterprises. Under current global loan operations, allocations to the increasingly important medical sector are still rare. The start of global loan operations with Apobank promises to significantly improve the reach of EIB support to this sector. Final beneficiaries are private and public sector promoters of any size and ownership, mostly independent doctors, dentists and pharmacists.

Environmental aspects
Procurement

Within the framework of the global loan, the Borrower will be requested to ensure compliance of the sub-projects with EU directives, as may be appropriate.

Within the framework of the global loan, the Borrower will be requested to ensure compliance of the sub-projects with EU directives, as may be appropriate.

Comments

Health.

Link to source
Summary sheet
Apobank Regional Development Global Loan I
Other links
Data sheet
APOBANK REGIONAL DEVELOPMENT GL I

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications